V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213592 | 20080016 | 1.65 | 77.3 | null | 2020-01-10 | 2020-01-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | null | FLUOROURACIL + MITOMYCIN + RT | 100327698 |
| 20213593 | 20080017 | 1.9 | 85.8 | Palliative (P) | 2021-06-01 | 2021-06-01 | Imatinib 400mg | 2 | N | IMATINIB | 101750529 |
| 20213594 | 20080018 | 1.61 | 65.3 | Neo-adjuvant (N) | null | 2017-01-17 | null | null | N | TRIAL | 100013005 |
| 20213595 | 20080019 | null | 42.6 | Palliative (P) | 2018-05-15 | 2018-05-16 | LANREOTIDE | 02 | N | LANREOTIDE | 101336991 |
| 20213598 | 20080021 | 1.75 | 82.6 | Palliative (P) | 2019-10-13 | 2019-10-20 | Trial Unspecified | N | N | TRIAL | 100783929 |
| 20213599 | 20080022 | 1.63 | null | Curative (C) | 2019-02-28 | 2019-03-16 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | null | FLUOROURACIL + MITOMYCIN + RT | 100901097 |
| 20213602 | 20080023 | 0 | 56 | Palliative (P) | 2017-01-21 | 2017-02-08 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | LANREOTIDE | 100019214 |
| 20213603 | 20080024 | 1.75 | 64.1 | Palliative (P) | 2016-05-04 | 2016-05-04 | IMATINIB | 99 | N | IMATINIB | 100862349 |
| 20213604 | 20080025 | 1.54 | 116.7 | Palliative (P) | 2016-12-06 | 2016-12-19 | IMATINIB | 02 | N | IMATINIB | 100897358 |
| 20213605 | 20080026 | 1.6 | null | Palliative (P) | 2017-06-04 | 2017-06-07 | Cape+Cisplatin+Trastuzumab Main | 02 | N | TRIAL | 101414041 |
| 20213607 | 20080027 | null | null | Palliative (P) | null | 2018-07-06 | Cape+Cisplatin+Trastuzumab Load | 02 | N | LANREOTIDE | 100741820 |
| 20213609 | 20080028 | 1.63 | 85.6 | Palliative (P) | 2018-08-25 | 2018-09-04 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101836650 |
| 20213611 | 20080029 | 1.82 | 75.5 | null | 2016-07-03 | 2016-07-03 | LANREOTIDE | 02 | null | LANREOTIDE | 100110166 |
| 20213613 | 20080030 | 1.53 | 62.5 | Curative (C) | 2017-08-03 | 2017-08-21 | Cape+Cisplatin+Trastuzumab Load | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100037530 |
| 20213614 | 20080031 | 1.67 | 72.2 | Curative (C) | 2019-04-12 | 2019-05-03 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | Y | FLUOROURACIL + MITOMYCIN + RT | 101670283 |
| 20213616 | 20080032 | 1.69 | 76.8 | Neo-adjuvant (N) | 2019-08-23 | 2019-09-06 | HCX (Cape + Cisp + Tras) - Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100809040 |
| 20213617 | 20080033 | 1.71 | 86 | Palliative (P) | 2018-08-31 | 2018-09-18 | HCX (Cape + Cisp + Tras) - Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101858310 |
| 20213618 | 20080034 | 1.67 | 82.4 | Curative (C) | 2018-02-25 | 2018-02-25 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100748019 |
| 20213619 | 20080035 | 1.65 | 90 | Curative (C) | 2016-04-04 | 2016-04-13 | Cape+Cisplatin+Trastuzumab Load | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 101355491 |
| 20213621 | 20080036 | 0 | 62.1 | null | 2019-11-03 | 2019-11-04 | LANREOTIDE | 02 | null | LANREOTIDE | 101545638 |
| 20213624 | 20080038 | 1.63 | 73.1 | Palliative (P) | 2018-11-10 | 2018-11-10 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101695196 |
| 20213625 | 20080039 | 1.6 | 127 | Palliative (P) | 2019-09-02 | 2019-09-02 | IMATINIB | 02 | N | IMATINIB | 101538773 |
| 20213626 | 20080040 | 1.8 | 84.6 | Palliative (P) | 2017-08-21 | 2017-09-03 | Cape+Cisplatin+Trastuzumab Load | 02 | N | TRIAL | 101843820 |
| 20213627 | 20080041 | 1.57 | 85.3 | Neo-adjuvant (N) | 2017-07-16 | 2017-07-30 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | IMATINIB | 101869127 |
| 20213629 | 20080043 | 1.55 | 83.65 | Palliative (P) | 2019-10-31 | 2019-11-16 | Trial Unspecified | 1 | N | TRIAL | 101779797 |
| 20213630 | 20080044 | 1.53 | 73 | Adjuvant (A) | 2017-12-13 | 2018-01-06 | HCX | 02 | N | IMATINIB | 101757802 |
| 20213631 | 20080045 | null | 46.4 | null | 2016-12-14 | 2016-12-19 | LANREOTIDE | 02 | N | LANREOTIDE | 101599194 |
| 20213633 | 20080046 | 1.72 | 59.78 | Palliative (P) | null | 2018-09-27 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101802498 |
| 20213637 | 20080048 | 1.67 | null | Palliative (P) | 2020-09-17 | 2020-09-30 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101482257 |
| 20213639 | 20080049 | 1.66 | 97 | Curative (C) | 2017-02-12 | 2017-02-19 | FLUOROURACIL + MITOMYCIN + RT | N | null | FLUOROURACIL + MITOMYCIN + RT | 100073221 |
| 20213640 | 20080050 | null | 47.9 | Palliative (P) | null | 2019-02-06 | Cape+Cisplatin+Trastuzumab Load | 02 | N | LANREOTIDE | 101465917 |
| 20213641 | 20080051 | null | null | Curative (C) | 2016-08-29 | 2016-09-11 | HCX (Cape + Cisp + Tras) - Load | 02 | N | IMATINIB | 100082249 |
| 20213642 | 20080052 | 0 | 70.55 | null | null | 2020-10-25 | LANREOTIDE | 02 | null | LANREOTIDE | 100837148 |
| 20213644 | 20080053 | 1.75 | 88.6 | Curative (C) | 2019-06-07 | 2019-06-07 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100689188 |
| 20213646 | 20080055 | 1.59 | 97.3 | Palliative (P) | 2019-04-08 | 2019-04-22 | HCX (Cape + Cisp + Tras) - Load | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101194452 |
| 20213648 | 20080057 | 1.57 | 74.4 | Curative (C) | 2016-09-24 | 2016-09-26 | FLUOROURACIL + MITOMYCIN + RT | 2 | Y | FLUOROURACIL + MITOMYCIN + RT | 100265545 |
| 20213649 | 20080058 | 1.6 | 70 | Palliative (P) | 2017-02-10 | 2017-02-10 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101471853 |
| 20213650 | 20080059 | 1.8 | 61.1 | Palliative (P) | 2019-03-06 | 2019-03-21 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100907422 |
| 20213652 | 20080060 | 1.6 | 70.4 | Not known (9) | 2019-02-23 | 2019-03-23 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | N | FLUOROURACIL + MITOMYCIN + RT | 101417359 |
| 20213653 | 20080061 | 1.7 | 70.6 | Curative (C) | 2018-02-23 | 2018-03-06 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 101575028 |
| 20213654 | 20080062 | 1.63 | 66 | Curative (C) | 2016-05-16 | 2016-06-10 | FLUOROURACIL + MITOMYCIN + RT | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100412663 |
| 20213655 | 20080063 | null | null | Curative (C) | 2016-07-01 | 2016-07-17 | FLUOROURACIL + MITOMYCIN + RT | N | N | FLUOROURACIL + MITOMYCIN + RT | 100522680 |
| 20213656 | 20080064 | 1.68 | 92 | null | 2017-11-26 | 2017-12-22 | Cape+Cisplatin+Trastuzumab Load | 02 | null | IMATINIB | 100301757 |
| 20213657 | 20080065 | 0 | 75.3 | null | 2016-11-29 | 2016-11-29 | Cape+Cisplatin+Trastuzumab Load | 02 | null | IMATINIB | 100605888 |
| 20213658 | 20080066 | 1.5 | 57.14 | Palliative (P) | 2016-08-22 | 2016-08-27 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100418921 |
| 20213659 | 20080067 | 1.65 | 101.6 | Neo-adjuvant (N) | 2016-03-16 | 2016-03-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100031840 |
| 20213660 | 20080068 | 1.79 | 55.2 | Curative (C) | 2018-07-02 | 2018-07-03 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100018479 |
| 20213661 | 20080069 | 1.75 | 92 | Curative (C) | 2017-11-24 | 2017-12-05 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | Y | FLUOROURACIL + MITOMYCIN + RT | 101863136 |
| 20213665 | 20080071 | 1.75 | 68.8 | Palliative (P) | 2019-01-05 | 2019-01-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101772041 |
| 20213666 | 20080072 | 1.75 | 71.05 | null | 2018-09-27 | 2018-09-27 | LANREOTIDE | 02 | null | LANREOTIDE | 100721515 |